• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    MEI Pharma, Inc. (MEIP)

    -NasdaqCM
    4.13 Down 0.04(0.96%) 4:00PM EST
    |After Hours : 4.20 Up 0.07 (1.69%) 4:19PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:4.17
    Open:4.14
    Bid:4.00 x 100
    Ask:4.46 x 1000
    1y Target Est:15.80
    Beta:-1.65
    Next Earnings Date:N/A
    Day's Range:4.09 - 4.32
    52wk Range:3.57 - 13.98
    Volume:261,481
    Avg Vol (3m):155,591
    Market Cap:89.24M
    P/E (ttm):N/A
    EPS (ttm):-1.47
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MEIP

    Comparison

    Symbol% ChgMkt Cap
    MEIPDown 0.96%89.24M
    AZNUp 2.74%91.07B
    SNYUp 1.81%122.84B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-1.50
    Quarterly EPS Est (Dec-14) :-0.39
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    MEI Pharma, Inc., an oncology company, focuses on the clinical development of novel therapies for the treatment of cancer. The company’s lead drug candidate is Pracinostat, an orally available histone deacetylase inhibitor, which is in Phase ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback